Psychiatry & Neurology Doctors in Ogema, MN Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Dr. Autumn Ann Ambroday, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 40520 County Highway 34, White Earth Tribal Mhc, Ogema, MN 56569 Phone: 218-983-6325    Fax: 952-479-1443

Dr. Michelle M Mehta, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: White Earth Mental Health Clinic, 40520 County Highway 34, Ogema, MN 56569 Phone: 218-983-6325

News Archive

Stage III lung cancer patients can benefit from concurrent chemo and radiation therapy

Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.

Kaiser roundup of health policy-related blog posts

While mainstream news coverage is still a primary source of information for the latest in policy debates and the health care marketplace, online blogs have become a significant part of the media landscape, often presenting new perspectives on policy issues and drawing attention to under-reported topics.

Researchers find more accurate method to screen for meningococcal infection

Researchers from the University of Missouri School of Medicine have found a more accurate method to screen for bacterial meningococcal infection in its early stages, when it's hardest to detect. According to the researchers, the method for diagnosis could save lives by getting patients treatment earlier, when the infection is most treatable.

Comprehensive investigation employing FRET to study amino acid transporter GAT1 reported

In the December 2009 issue of the Journal of General Physiology (www.jgp.org), Moss et al. report a comprehensive investigation employing F-rster resonance energy transfer (FRET) to study the {gamma}-amino acid (GABA) transporter GAT1, a member of the family that includes transporters for neurotransmitters dopamine (DAT), serotonin (SERT), norepinephrine (NET) and glycine (GlyT).

European Commission grants Marketing Authorization for empagliflozin for treatment of type 2 diabetes

The European Commission has granted Marketing Authorisation for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor from Boehringer Ingelheim and Eli Lilly and Company.

Read more Medical News

› Verified 3 days ago